[The rôle of catecholamines in the clinical manifestations of the hyper- and hypothyroidism syndromes].
D000818:Animals; D004285:Dogs; D004837:Epinephrine / Q000502:physiology*; D006111:Graves Disease / Q000378:metabolism; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy / Q000378:metabolism*; D007037:Hypothyroidism / Q000188:drug therapy / Q000378:metabolism*; D051379:Mice; D009638:Norepinephrine / Q000502:physiology*; D011433:Propranolol / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use; D013610:Tachycardia / Q000209:etiology; D013963:Thyroid Hormones / Q000502:physiology*
D013565:Sympatholytics; D013963:Thyroid Hormones; D011433:Propranolol; D009638:Norepinephrine; D004837:Epinephrine
La part des catécholamines dans l'expression clinique des syndromes d'hyper et d'hypothyréose.